# Orchestra BioMed Holdings, Inc. (OBIO) insider trading

> In the 12 months to Nov 10, 2026, 2 OBIO insiders reported open-market sales of $439.2K across 7 filings; 6 insiders bought $509.9K.

Canonical: https://massive.com/quote/obio/insider-trading
Latest filing: 2026-11-09 (last 12 months; source: SEC EDGAR)
Source: Massive (https://massive.com/docs/llms.txt)

## Summary

| Measure | Value | Detail |
| --- | --- | --- |
| Open-market sales | $439.2K | 7 filings · 2 insiders |
| Open-market purchases | $509.9K | 13 filings |
| Pre-arranged sales (10b5-1) | 6 of 7 | $439.1K of $439.2K sold (100%) |

## Open-market trades by insider

| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
| --- | --- | --- | --- | --- | --- | --- |
| Darren Sherman | Officer (see filing) | $439.1K | $10.7K | 7 | 100% of sales | 2026-11-03 |
| Eric S. Fain | Director | — | $182.6K | 2 | — | 2026-11-09 |
| David P. Hochman | Officer (see filing) | — | $174.2K | 6 | — | 2026-11-09 |
| David Pacitti | Director | — | $100.0K | 1 | — | 2026-11-09 |
| Jason Aryeh | Director | — | $37.5K | 2 | — | 2026-05-20 |
| Andrew Lawrence Taylor | Chief Financial Officer | — | $5.0K | 1 | — | 2026-11-09 |
| Roderick Wong | 10% owner | $132 | — | 1 | — | 2026-04-29 |

## Open-market trades by filing

20 filings in the last 12 months, newest first.

| Filed | Traded | Insider | Role | Type | Shares | Avg price | Value | Held after | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 2026-11-09 | 2026-11-09 | Andrew Lawrence Taylor | Chief Financial Officer | Purchase | 1,000 | $5.00 | $5.0K | 590,989 | — |
| 2026-11-09 | 2026-11-09 | David P. Hochman | Officer (see filing) | Purchase | 5,000 | $5.00 | $25.0K | 437,916 | — |
| 2026-11-09 | 2026-11-09 | David Pacitti | Director | Purchase | 20,000 | $5.00 | $100.0K | 74,750 | — |
| 2026-11-09 | 2026-11-09 | Eric S. Fain | Director | Purchase | 20,000 | $5.00 | $100.0K | 119,630 | — |
| 2026-11-03 | 2026-11-02 | Darren Sherman | Officer (see filing) | Sale (10b5-1) | 15,000 | $5.74 | $86.1K | 1,104,402 | — |
| 2026-10-02 | 2026-10-01 | Darren Sherman | Officer (see filing) | Sale (10b5-1) | 15,000 | $6.36 | $95.4K | 1,119,402 | — |
| 2026-09-08 | 2026-09-03 | David P. Hochman | Officer (see filing) | Purchase | 10,000 | $4.79 | $47.9K | 1,070,746 | — |
| 2026-09-02 | 2026-09-01 | Darren Sherman | Officer (see filing) | Sale (10b5-1) | 15,000 | $4.94 | $74.1K | 1,134,402 | — |
| 2026-08-28 | 2026-08-26 | Darren Sherman | Officer (see filing) | Purchase | 2,000 | $5.33 | $10.7K | 2,000 | — |
| 2026-08-04 | 2026-08-03 | Darren Sherman | Officer (see filing) | Sale (10b5-1) | 15,000 | $4.09 | $61.4K | 1,154,327 | — |
| 2026-07-02 | 2026-07-01 | Darren Sherman | Officer (see filing) | Sale (10b5-1) | 15,000 | $4.27 | $64.0K | 1,169,327 | — |
| 2026-06-02 | 2026-06-01 | Darren Sherman | Officer (see filing) | Sale (10b5-1) | 15,000 | $3.87 | $58.1K | 1,184,327 | — |
| 2026-06-02 | 2026-06-01 | David P. Hochman | Officer (see filing) | Purchase | 5,000 | $3.83 | $19.2K | 1,064,029 | — |
| 2026-05-20 | 2026-05-18 | Jason Aryeh | Director | Purchase | 665 | $3.75 | $2.5K | 118,118 | — |
| 2026-05-19 | 2026-05-15 | David P. Hochman | Officer (see filing) | Purchase | 5,000 | $3.77 | $18.9K | 1,059,029 | — |
| 2026-05-19 | 2026-05-15 | Jason Aryeh | Director | Purchase | 8,971 | $3.90 | $35.0K | 117,453 | — |
| 2026-05-18 | 2026-05-14 | Eric S. Fain | Director | Purchase | 20,000 | $4.13 | $82.6K | 91,709 | — |
| 2026-04-29 | 2026-04-27 | Roderick Wong | 10% owner | Sale | 32 | $4.13 | $132 | 9,556,063 | — |
| 2026-03-16 | 2026-03-13 | David P. Hochman | Officer (see filing) | Purchase | 10,000 | $4.29 | $42.9K | 1,086,467 | — |
| 2025-11-17 | 2025-11-14 | David P. Hochman | Officer (see filing) | Purchase | 5,000 | $4.07 | $20.4K | 612,822 | — |

## Other insider activity (not market trades)

- Tax withholding: 32 records
- Grants and awards: 7 records
- Other: 1 record

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

## How to read this page

- **Open-market purchase or sale**: A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- **Pre-arranged (10b5-1)**: The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- **Filing date**: Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
- **Counted once**: When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.

## FAQ

### How current is OBIO’s insider data?

These are OBIO Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.

### What counts as an open-market buy or sell?

Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.

## Live data

This page joins two Massive endpoints: Form 4 filings and daily prices. The OBIO Form 4 request:

- `GET https://api.massive.com/stocks/filings/vX/form-4?tickers=OBIO&filing_date.gte=2025-11-10&sort=filing_date.desc&limit=500`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Orchestra BioMed Holdings, Inc. (OBIO) stock price](https://massive.com/quote/obio.md)
- [Recent insider trading](https://massive.com/quote/insider-trading.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms